News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,876 Results
Type
Article (39694)
Company Profile (247)
Press Release (658935)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204166)
Career Advice (2007)
Deals (35418)
Drug Delivery (95)
Drug Development (81046)
Employer Resources (172)
FDA (16181)
Job Trends (14858)
News (345187)
Policy (32538)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49432)
ALS (88)
Alzheimer's disease (1378)
Antibody-drug conjugate (ADC) (125)
Approvals (16185)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (278)
Cancer (2260)
Cardiovascular disease (175)
Career advice (1676)
Career pathing (30)
CAR-T (151)
Cell therapy (423)
Cervical cancer (19)
Clinical research (65988)
Collaboration (833)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2589)
CRISPR (40)
C-suite (241)
Cystic fibrosis (100)
Data (2211)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (271)
Diagnostics (6370)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86642)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112414)
Executive appointments (722)
FDA (17446)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (105)
Generative AI (19)
Gene therapy (302)
GLP-1 (709)
Government (4416)
Grass and pollen (4)
Guidances (68)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2731)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16508)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (468)
Leadership (17)
Legal (7909)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13378)
Medtech (13383)
Mergers & acquisitions (19455)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1913)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (364)
Opinion (204)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57300)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20559)
Phase II (29057)
Phase III (21649)
Pipeline (1208)
Policy (139)
Postmarket research (2563)
Preclinical (8739)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22284)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3576)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (690)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (37)
Last 7 days (851)
Last 30 days (2500)
Last 365 days (32637)
2025 (10773)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37840)
Australia (6184)
California (6143)
Canada (2020)
China (524)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81256)
Florida (912)
Georgia (206)
Idaho (57)
Illinois (536)
India (25)
Indiana (308)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4575)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1727)
New Mexico (28)
New York (1750)
North Carolina (967)
North Dakota (8)
Northern California (2687)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2308)
Tennessee (101)
Texas (909)
United States (23154)
Utah (182)
Virginia (146)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (54)
698,876 Results for "electromed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Electromed, Inc. to Participate in the 2024 Sidoti June Small-Cap Virtual Conference
Electromed, Inc., a leader in innovative airway clearance technologies, announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti June Small-Cap Virtual Conference on June 12-13, 2024.
June 3, 2024
·
1 min read
Business
Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter
Electromed, Inc., a leader in innovative airway clearance technologies, announced financial results for the three months ended December 31, 2023.
February 13, 2024
·
10 min read
BioMidwest
Electromed, Inc. to Participate in the 2024 Sidoti March Small-Cap Virtual Conference
Electromed, Inc. today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Sidoti March Small-Cap Virtual Conference on March 13-14, 2024.
February 28, 2024
·
1 min read
BioMidwest
Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Electromed, Inc., a leader in innovative airway clearance technologies, announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 17-18, 2024.
April 8, 2024
·
1 min read
Business
Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ET
Electromed, Inc. today announced that it will issue its financial results press release for the fiscal 2024 third quarter ended March 31, 2024, on May 7, 2024 after the close of the stock market.
April 23, 2024
·
1 min read
BioMidwest
Electromed, Inc. to Participate in the Virtual 2024 Lytham Partners Investor Select Conference
Electromed, Inc. today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual 2024 Lytham Partners Investor Select Conference on February 1, 2024.
January 24, 2024
·
1 min read
Business
Electromed, Inc. Announces Fiscal 2024 First Quarter Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2023 (“Q1 FY 2024”).
November 7, 2023
·
9 min read
Business
Electromed, Inc. Schedules its Second Quarter Fiscal 2024 Financial Results Conference Call for February 13, 2024 at 5:00 p.m. ET
Electromed, Inc. today announced that it will issue its financial results press release for the fiscal 2024 second quarter ended December 31, 2023, on February 13, 2024 after the close of the stock market.
January 30, 2024
·
1 min read
Business
Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (“Q4 FY 2023”) and full year (“FY 2023”) ended June 30, 2023.
August 22, 2023
·
14 min read
BioMidwest
Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Electromed, Inc. today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin NY Grand Central in New York City.
November 1, 2023
·
1 min read
1 of 69,888
Next
